Fri, Jul 25, 2014, 3:12 AM EDT - U.S. Markets open in 6 hrs 18 mins

Recent

% | $
Click the to save as a favorite.

Celgene Corp. (CELG) Message Board

pkornie 130 posts  |  Last Activity: 6 hours ago Member since: Apr 24, 2007
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • pkornie@sbcglobal.net by pkornie May 8, 2014 12:57 AM Flag

    2 Replies to otistongee69

    the_quintupler • 5 hours ago Flag

    3
    users liked this posts

    users disliked this posts
    0
    Reply

    .

    .
    Post hidden because you ignored this user

    users disliked this posts
    0
    Reply

    .

    .
    Post hidden because you ignored this user

    Sentiment: Strong Buy

  • Reply to

    Re: WHOCares.

    by pkornie May 6, 2014 12:20 PM
    pkornie@sbcglobal.net pkornie May 7, 2014 3:55 PM Flag

    Re: iv92267
    2 posts | Last Activity: 11 minutes ago
    Member since: Feb 4, 2012

    o.

    .

    Re: WHOCares.
    .

    http://finance.yahoo.com/q/ta?t=my&s=AAPL&l=on&z=l&q=l&c=gild&ql=1

    http://finance.yahoo.com/q/ta?t=my&s=GILD&l=on&z=l&q=l&c=aapl&ql=1

    Sentiment: Strong Buy

    o.

    .

    Sentiment: Strong Buy

  • Reply to

    Re: WHOCares.

    by pkornie May 6, 2014 12:20 PM
    pkornie@sbcglobal.net pkornie May 7, 2014 3:42 PM Flag

    Re: iv92267
    1 post | Last Activity: 13 minutes ago
    Member since: Feb 4, 2012

    o.

    .

    http://finance.yahoo.com/q/ta?t=my&s=AAPL&l=on&z=l&q=l&c=gild&ql=1

    http://finance.yahoo.com/q/ta?t=my&s=GILD&l=on&z=l&q=l&c=aapl&ql=1

    o.

    .

    Sentiment: Strong Buy

  • Reply to

    Re: WHOCares.

    by pkornie May 6, 2014 12:20 PM
    pkornie@sbcglobal.net pkornie May 7, 2014 10:46 AM Flag

    Re: GIFT US.

    WhatAbou(HRS)todayThru10th.

    o.

    .

    Re: WHOCares.
    .

    http://finance.yahoo.com/q/ta?t=my&s=AAPL&l=on&z=l&q=l&c=gild&ql=1

    http://finance.yahoo.com/q/ta?t=my&s=GILD&l=on&z=l&q=l&c=aapl&ql=1

    Sentiment: Strong Buy

    Sentiment: Strong Buy

  • pkornie@sbcglobal.net by pkornie May 6, 2014 12:20 PM Flag

    http://finance.yahoo.com/q/ta?t=my&s=AAPL&l=on&z=l&q=l&c=gild&ql=1

    http://finance.yahoo.com/q/ta?t=my&s=GILD&l=on&z=l&q=l&c=aapl&ql=1

    Sentiment: Strong Buy

  • Reply to

    Re: POS Cuddblow.

    by pkornie Feb 20, 2014 1:45 AM
    pkornie@sbcglobal.net pkornie May 6, 2014 10:51 AM Flag

    Re: (DDW), (HRS), (ShrHolderMeet).

    o.

    .

    Sentiment: Strong Buy

  • Reply to

    Re: POS Cuddblow.

    by pkornie Feb 20, 2014 1:45 AM
    pkornie@sbcglobal.net pkornie May 6, 2014 10:24 AM Flag

    Re: pinocchio_motivation_speaker
    14 posts | Last Activity: 2 minutes 23 seconds ago
    Member since: Apr 16, 2014

    o.

    .

    Sentiment: Strong Buy

  • Reply to

    Re: POS Cuddblow.

    by pkornie Feb 20, 2014 1:45 AM
    pkornie@sbcglobal.net pkornie May 6, 2014 3:30 AM Flag

    Re: AsfraBeneca Rejects Pfyzer's Lastest Opper

    o.

    .

    Sentiment: Strong Buy

  • Reply to

    Re: POS Cuddblow.

    by pkornie Feb 20, 2014 1:45 AM
    pkornie@sbcglobal.net pkornie May 5, 2014 12:13 PM Flag

    Re: Oknows.B(Buy't(Buy_It).(Buyt).

    http://finance.yahoo.com/q/ta?s=GILD&t=1d&l=on&z=l&q=l&p=b&a=&c=

    Sentiment: Strong Buy

  • Reply to

    Re: I'mGoingToReoSoon.

    by pkornie Feb 7, 2014 6:14 PM
    pkornie@sbcglobal.net pkornie May 5, 2014 10:48 AM Flag

    Re: WhereIsSusan.

    o.

    .

    Sentiment: Strong Buy

  • Reply to

    Re: I'mGoingToReoSoon.

    by pkornie Feb 7, 2014 6:14 PM
    pkornie@sbcglobal.net pkornie May 5, 2014 10:47 AM Flag

    Re: technical_fundamental
    10 posts | Last Activity: 18 minutes ago
    Member since: Apr 23, 2014

    o.

    .

    Sentiment: Strong Buy

  • Reply to

    Re: ReportTheFAQ./IGNORE.

    by pkornie Jan 28, 2014 12:39 AM
    pkornie@sbcglobal.net pkornie May 5, 2014 9:39 AM Flag

    Re: O-B(Buy)somePFE.or_LEXG.OB

    o.

    .

    http://finance.yahoo.com/q/ta?t=my&s=GILD&l=on&z=l&q=l&c=pfe&ql=1

    o.

    .

    Sentiment: Strong Buy

  • Reply to

    Re: ReportTheFAQ./IGNORE.

    by pkornie Jan 28, 2014 12:39 AM
    pkornie@sbcglobal.net pkornie May 5, 2014 9:32 AM Flag

    Re: O_WhenToB(Buy)Mo.

    o.

    .

    Sentiment: Strong Buy

  • Reply to

    Re:_YouB(Buy)shiStocksYouGetShi.

    by pkornie Apr 24, 2014 4:23 AM
    pkornie@sbcglobal.net pkornie May 4, 2014 10:45 AM Flag

    Re:_http://finance.yahoo.com/mbview/threadview/;_ylt=AvMjyKJW_EgS3RHB9YP9Q1reAohG;_ylu=X3oDMTB2Y252cDRkBHBvcwMxOQRzZWMDTWVkaWFNc2dCb2FyZHNYSFJVbHQ-;_ylg=X3oDMTBhYWM1a2sxBGxhbmcDZW4tVVM-;_ylv=3?&bn=604616e4-d592-3744-a14e-c3ff33204dec&tid=1390887544519-d93ee252-ef87-4b85-8c39-14ed32975644

    o.

    .

    Sentiment: Hold

  • Reply to

    Re: ReportTheFAQ./IGNORE.

    by pkornie Jan 28, 2014 12:39 AM
    pkornie@sbcglobal.net pkornie May 4, 2014 10:42 AM Flag

    Re: http://en.wikipedia.org/wiki/Gilead_Sciences

    Sentiment: Strong Buy

  • Reply to

    Re: ReportTheFAQ./IGNORE.

    by pkornie Jan 28, 2014 12:39 AM
    pkornie@sbcglobal.net pkornie May 4, 2014 10:25 AM Flag

    Re: Gilead has 16 products on the market.

    Product Portfolio

    Brand Name

    Drug Name(s)

    Indication

    Date Approved (USA)[39]

    Marketing Partner(s)

    U.S. Patent Expiration[2]

    European Patent Expiration[2]

    AmBisome liposomal amphotericin B fungal infection, cryptococcal meningitis, Aspergillus, Candida, Cryptococcus infections 1997-08-11 Astellas Pharma(USA)Rapiscan(EU) 2016 2008
    Atripla tenofovir, emtricitabine, and efavirenz HIV, AIDS 2006-07-12 Bristol-Myers Squibb 2021 2018
    Cayston Aztreonam Cystic Fibrosis 2010-02-22 2021 2021
    Complera/Eviplera tenofovir, emtricitabine, and rilpivirine HIV, AIDS 2011-08-10 Johnson and Johnson
    Emtriva emtricitabine HIV, AIDS 2003-07-02 2021 2016
    Flolan epoprostenol sodium pulmonary hypertension 1995-09-20 GlaxoSmithKline expired expired
    Hepsera adefovir dipivoxil hepatitis B (HBV) 2002-09-20 2014 2011
    Letairis ambrisentan Pulmonary arterial hypertension 2007-06-15 GlaxoSmithKline 2015 2015
    Lexiscan regadenoson myocardial perfusion imaging 2008-04-10 Astellas 2019 2020
    Macugen pegaptanib sodium solution age-related macular degeneration 2004-12-17 OSI and Pfizer 2017 2017
    Ranexa ranolazine angina 2006-01-27 Hoffmann–La Roche 2019 2019
    Sovaldi sofosbuvir Hepatitis C 2013-12-06
    Stribild elvitegravir, cobicistat, emtricitabine, tenofovir HIV, AIDS 2012-08-27
    Tamiflu oseltamivir phosphate influenza 1999-10-27 Hoffmann–La Roche 2016 2016
    Truvada emtricitabine and tenofovir HIV, AIDS 2004-08-02 2021 2018
    Tybost cobicistat HIV, AIDS 2013-09-25
    Viread tenofovir HIV, AIDS, hepatitis B 2001-10-26 2017 2018
    Vistide cidofovir CMV retinitis 1996-06-26 Pfizer expired expired

    Product pipeline[edit]

    Gilead's pipeline[40] focuses on HCV, HIV, cardiovascular and respiratory disorders.

    Drug Name

    Description

    Potential Indication

    Testing Phase[41]

    Cobicistat/Tybost (formerly GS-9350) Pharmacokinetic enhancer HIV/AIDS submitted for US + EU approval
    Elvitegravir (formerly GS-9137) Integrase inhibitor HIV/AIDS submitted for US + EU approval
    Single Tablet Regimen elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide fumarate HIV/AIDS Phase III
    Single Tablet Regimen darunavir, cobicistat, emtricitabine, and tenofovir alafenamide fumarate HIV/AIDS Phase II
    Single Tablet Regimen sofosbuvir and ledipasvir Hepatitis C Phase III
    GS-5816 pan-genotypic NS5A inhibitor Hepatitis C Phase II
    GS-9451 NS3 Protease inhibitor Hepatitis C Phase II
    GS-9669 non-nucleoside NS5B inhibitor Hepatitis C Phase II
    Ledipasvir (formerly GS-5885) NS5A inhibitor Hepatitis C Phase III
    GS-9620 TLR-7 agonist Hepatitis C/Hepatitis B Phase I
    Tenofovir alafenamide fumarate (TAF) (formerly GS-7340) nucleotide reverse transcriptase inhibitor Hepatitis B Phase I
    GS-4774 Tarmogen T cell immunity stimulator Hepatitis B Phase I
    Simtuzumab (formerly GS-6624) Humanized monoclonal antibody Liver Fibrosis/Idiopathic Pulmonary Fibrosis/Myelofibrosis/Pancreatic Cancer Phase II
    Idelalisib PI3K delta inhibitor Chronic Lymphocytic Leukemia/Indolent non-Hodgkin’s Lymphoma Phase III
    GS-9973 Syk inhibitor B-Cell Malignancies Phase II
    GS-9820 PI3K delta inhibitor Lymphoid Malignancies Phase II
    GS-5745 MMP9 mAb inhibitor Ulcerative Colitis/Solid Tumors Phase I
    Momelotinib JAK inhibitor Myelofibrosis Phase II
    Ranolazine Late sodium current inhibitor Coronary Artery Disease/Diabetes Phase III
    Single Tablet Regimen Ranolazine and Dronedarone Paroxysmal Atrial Fibrillation Phase II
    GS-6615 Ischemic Heart Disease and Arrhythmias Phase I
    GS-5806 Respiratory Syncytial Virus Phase II

    Sentiment: Strong Buy

  • Reply to

    Re: I'mGoingToReoSoon.

    by pkornie Feb 7, 2014 6:14 PM
    pkornie@sbcglobal.net pkornie May 3, 2014 6:40 PM Flag

    Re: PorkBellysUPyoSasB(BuyGILTY).
    Questions.

    No.

    o.

    .

    Sentiment: Strong Buy

  • Reply to

    Re: I'mGoingToReoSoon.

    by pkornie Feb 7, 2014 6:14 PM
    pkornie@sbcglobal.net pkornie May 3, 2014 6:33 PM Flag

    Re: marcel_dupre_symphony
    33 posts | Last Activity: 30 minutes ago
    Member since: Jan 23, 2014

    o.

    .

    Sentiment: Strong Buy

  • Reply to

    Re: I'mGoingToReoSoon.

    by pkornie Feb 7, 2014 6:14 PM
    pkornie@sbcglobal.net pkornie May 3, 2014 5:16 PM Flag

    Re: Reply to nerbes by x2003 •Apr 39, 2014 9:37 PM

    WhensDaSp.

    o.

    .

    Sentiment: Strong Buy

  • Reply to

    Re: I'mGoingToReoSoon.

    by pkornie Feb 7, 2014 6:14 PM
    pkornie@sbcglobal.net pkornie May 3, 2014 11:18 AM Flag

    Re: honor.knafl235
    5 posts | Last Activity: 1 hour 29 minutes ago
    Member since: May 1, 2014

    o.

    .

    Sentiment: Strong Buy

CELG
86.19-2.93(-3.29%)Jul 24 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.